Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Keros Therapeutics
KROS
$199M
| $1.57M | ﹤0.01% |
99,100
-22,030
| -18% | -$325K |
|
3027
Global X Artificial Intelligence & Technology ETF
AIQ
$10.2B
| $1.57M | ﹤0.01% |
+31,721
| New | +$1.44M |
|
3028
PUT
Vertex Pharmaceuticals
VRTX
$121B
| $1.57M | ﹤0.01% |
4,000
| – | – |
|
3029
Enact Holdings
ACT
$6.61B
| $1.56M | ﹤0.01% |
40,746
-13,380
| -25% | -$496K |
|
3030
Backblaze
BLZE
$823M
| $1.56M | ﹤0.01% |
168,290
-25,722
| -13% | -$189K |
|
|
JOYY
3031
JOYY Inc
JOYY
$3.71B
| $1.56M | ﹤0.01% |
26,551
+2,912
| +12% | +$160K |
|
3032
Amplitude
AMPL
$1.18B
| $1.56M | ﹤0.01% |
145,128
-30,956
| -18% | -$367K |
|
|
FVR
3033
FrontView REIT
FVR
$475M
| $1.55M | ﹤0.01% |
113,356
-6,073
| -5% | -$77.7K |
|
3034
PUT
GSK
GSK
$104B
| $1.55M | ﹤0.01% |
+36,000
| New | +$1.41M |
|
3035
Covenant Logistics
CVLG
$894M
| $1.55M | ﹤0.01% |
71,667
-3,660
| -5% | -$87.5K |
|
3036
Assured Guaranty
AGO
$3.66B
| $1.55M | ﹤0.01% |
18,335
-10,898
| -37% | -$906K |
|
3037
CALL
Zillow
Z
$7.79B
| $1.54M | ﹤0.01% |
+20,000
| New | +$1.63M |
|
3038
Vanguard Dividend Appreciation ETF
VIG
$111B
| $1.54M | ﹤0.01% |
7,140
-740
| -9% | -$155K |
|
3039
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $1.54M | ﹤0.01% |
24,961
-9,949
| -28% | -$616K |
|
3040
Southern Missouri Bancorp
SMBC
$852M
| $1.54M | ﹤0.01% |
29,285
-1,520
| -5% | -$84.7K |
|
3041
Yext
YEXT
$547M
| $1.54M | ﹤0.01% |
180,565
-59,072
| -25% | -$501K |
|
3042
Limbach Holdings
LMB
$855M
| $1.53M | ﹤0.01% |
15,805
-7,037
| -31% | -$847K |
|
3043
First Mid Bancshares
FMBH
$1.39B
| $1.53M | ﹤0.01% |
40,515
-6,842
| -14% | -$267K |
|
3044
PUT
AstraZeneca
AZN
$263B
| $1.53M | ﹤0.01% |
10,000
| – | – |
|
3045
CALL
Telesat
TSAT
$567M
| $1.53M | ﹤0.01% |
57,900
| – | – |
|
3046
DXC Technology
DXC
$1.82B
| $1.53M | ﹤0.01% |
112,503
-148,929
| -57% | -$2.11M |
|
3047
EverQuote
EVER
$892M
| $1.53M | ﹤0.01% |
66,956
-8,423
| -11% | -$203K |
|
3048
Beazer Homes USA
BZH
$877M
| $1.53M | ﹤0.01% |
62,349
-148,927
| -70% | -$3.66M |
|
3049
Toyota
TM
$224B
| $1.53M | ﹤0.01% |
7,990
+3,227
| +68% | +$608K |
|
|
THR
3050
DELISTED
Thermon Group Holdings
THR
| $1.52M | ﹤0.01% |
57,071
-16,374
| -22% | -$440K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.